BlackRock Files Schedule 13G for Immix Biopharma
BlackRock filed a Schedule 13G for Immix Biopharma. The filing date is listed as October 27, 20.
Related stories
AMAT Shares Fall 2.58% as Headline Cites Record Q4 Revenue
The headline also says 2027 demand is seen above 30%, but provides no further context.
M impact | EQUITY | Nov 14, 2026, 08:02 AM UTC
MSCI to Drop MSTR; CEO Sees Low Impact; $6.8B Bitcoin Loss
M impact | EQUITY | Nov 14, 2026, 08:02 AM UTC
IndiGo Says Global Microsoft Service Disruption Is Fully Resolved
IndiGo said a global Microsoft service disruption affecting its email support services has been fully resolved.
M impact | EQUITY | Nov 14, 2026, 07:36 AM UTC
FAA Tech Failure Grounds Flights for Nearly Five Hours
Air travel ground to a halt for almost five hours Friday after an overloaded air traffic control system failed, snarling operations at Sea-Tac.
M impact | EQUITY | Nov 14, 2026, 07:32 AM UTC
Microsoft Restores Outlook and Teams After Global Outage
Microsoft says service to Outlook and Teams has been restored after a global outage.
M impact | EQUITY | Nov 14, 2026, 07:23 AM UTC
Procter & Gamble’s St. Louis Operation Marks 100 Years
A Q&A discusses the operation’s history, AI and Cascade dishwasher pods.
M impact | EQUITY | Nov 14, 2026, 07:17 AM UTC